Anesiva safeguards future with Arcion merger
This article was originally published in Scrip
Executive Summary
Anesiva has staved off the threat of liquidation after merging with the privately held Arcion Therapeutics. As a victim of the credit crisis, Anesiva was presented with little option other than to consolidate as it struggled for financing.